For us,
Every story is special.
Tell us your story and we'll help you make it a reality. We look forward to hearing from you.
Endometriosis treatment is a cornerstone of improving patients' quality of life, managing pain, and, in many cases, preserving or restoring fertility. Unlike other conditions, there is no single, universal treatment. Endometriosis is a complex, chronic disease with varying degrees of severity, so the approach must be individualized.
Endometriosis is a common gynecological disease affecting millions of women of reproductive age. Despite its high prevalence, many patients take years to receive a diagnosis. This occurs because endometriosis can be asymptomatic, or its symptoms can be normalized or confused with other gynecological, digestive, or urological disorders.
Polycystic ovary syndrome (PCOS) is a complex endocrine condition that affects approximately 10% of women of reproductive age. This hormonal disorder is one of the most common causes of female infertility, interfering with the natural processes of ovulation and fertilization.
Is having polycystic ovaries the same as having PCOS? Although often used interchangeably, having polycystic ovaries and suffering from polycystic ovary syndrome (PCOS) are two different conditions. At Inebir, our fertility clinic in Seville, we frequently see women with questions about their hormonal diagnosis and fertility.
For fertility, the relationship between endometriosis and pregnancy is a major concern for many women of reproductive age. Today more than ever, speaking openly about endometriosis and pregnancy is essential to inform and empower those facing these challenges.
Endometriosis is a chronic gynecological condition that affects many women of reproductive age. It occurs when tissue similar to the endometrium grows outside the uterus, affecting organs such as the ovaries, fallopian tubes, intestines, and bladder. At Inebir, our team of endometriosis specialists in Seville offers a comprehensive and personalized approach to its diagnosis and treatment.
INEBIR, in collaboration with the Software Systems Engineering and Science Group at the University of Seville, has developed an artificial intelligence (AI) model for the early detection of endometriosis. This project, led by Doctors José Navarro-Pando and Ana Teresa Marcos, was published in January 2025 in the prestigious scientific journal Expert Systems with Applications.
Endometriosis is often described as a gynecological disease, but this simplistic approach underestimates its complexity and profound impact on the women who suffer from it. More than just a medical condition, endometriosis is a multisystemic challenge that affects not only the reproductive system, but also the immune, digestive, and urinary systems, and in many cases, the mental and emotional health of patients.
Endometriosis is a chronic, estrogen-dependent disease characterized by the presence of endometrial-like tissue outside the uterus. It affects up to 10% of women of reproductive age and is a leading cause of chronic pelvic pain and infertility. While treatments typically focus on hormone regulation and surgery, the exploration of glucagon-like peptide-1 (GLP-1) receptor agonists has introduced a potential novel approach to treating endometriosis.
Endometriosis is an enigmatic disease whose origin we don't really know and for which we have no cure.
